loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Meningococcal Polysaccharide Vaccine Group W 135 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanofi

02 1GSK

03 1Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Group W-135 Meningococcal Polysaccharide

Brand Name : Menactra

Dosage Form : VAC

Dosage Strength : 4ug/0.5ml

Packaging : 0.5X1ug/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Neisseria Meningitides Purified Polysaccharides Group A, C, W135, Y

Brand Name : Mencevax ACW135Y

Dosage Form : INJ

Dosage Strength : 50ug/0.5ml

Packaging : 0.5X10ug/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135

Brand Name : NIMENRIX

Dosage Form : KIT

Dosage Strength : 5MCG/0.5ML

Packaging : 0.5ML/10X0.5ML

Approval Date :

Application Number : 2402904

Regulatory Info : Schedule D

Registration Country : Canada

blank